Kevin S. Gould is VP at BIO-TECHNE Corp (TECH). They have made 1 open-market trade across 1 company since 2016, most recently 2017-07-09.
CIK 0001662638
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TECH | 1,355 | $98K |
Shares reported on the most recent Form 4, priced at the 2017-07-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TECH | SELL | 2016-09-08 | 2016-09-12 | $110.50 | $58K | +2.5% | -1.6% | -1.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.